Oxalatoplatin
Categorie
Oxalatoplatin Les marques, Oxalatoplatin Analogs
Oxalatoplatin Les marques melange
Oxalatoplatin Formule chimique
Oxalatoplatin RX lien
Oxalatoplatin FDA fiche
Oxalatoplatin msds (fiche de securite des materiaux)
Oxalatoplatin Synthese de reference
Oxalatoplatin Poids moleculaire
Oxalatoplatin Point de fusion
Oxalatoplatin H2O Solubilite
Oxalatoplatin Etat
Oxalatoplatin LogP
Oxalatoplatin Formes pharmaceutiques
Oxalatoplatin Indication
Oxalatoplatin Pharmacologie
Oxalatoplatin Absorption
Oxalatoplatin Toxicite
Oxalatoplatin Information pour les patients
Patients and patientsí caregivers should be informed of the expected side effects of ELOXATIN, particularly its neurologic effects, both the acute, reversible effects, and the persistent neurosensory toxicity. Patients should be informed that the acute neurosensory toxicity may be precipitated or exacerbated by exposure to cold or cold objects. Patients should be instructed to avoid cold drinks, use of ice, and should cover exposed skin prior to exposure to cold temperature or cold objects.
Patients must be adequately informed of the risk of low blood cell counts and instructed to contact their physician immediately should fever, particularly if associated with persistent diarrhea, or evidence of infection develop.
Patients should be instructed to contact their physician if persistent vomiting, diarrhea, signs of dehydration, cough or breathing difficulties occur, or signs of allergic reaction appear.
